相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of polyphenols in combating Type 2 Diabetes and insulin resistance
Moyad Shahwan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)
Alzheimer's Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer's Disease and Type 2 Diabetes
Michalis Michailidis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
3. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes-2021
DIABETES CARE (2021)
The Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability-A Pilot Study
Piotr Alster et al.
FRONTIERS IN NEUROLOGY (2021)
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Matthew J. Page et al.
PLOS MEDICINE (2021)
Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia A Randomized Clinical Trial
Suzanne Craft et al.
JAMA NEUROLOGY (2020)
Multi-Loop Model of Alzheimer Disease: An Integrated Perspective on the Wnt/GSK3β, α-Synuclein, and Type 3 Diabetes Hypotheses
Nicholas G. Norwitz et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
Pouya Saeedi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Unraveling Binding Mechanism of Alzheimer's Drug Rivastigmine Tartrate with Human Transferrin: Molecular Docking and Multi-Spectroscopic Approach towards Neurodegenerative Diseases
Anas Shamsi et al.
BIOMOLECULES (2019)
History and progress of hypotheses and clinical trials for Alzheimer's disease
Pei-Pei Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer's Disease and Type 2 Diabetes
Carmen Infante-Garcia et al.
MOLECULAR NEUROBIOLOGY (2018)
Novel dual incretin agonist peptide with antidiabetic and neuroprotective potential
N. M. Pathak et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Metformin treatment prevents amyloid plaque deposition and memory impairment in APP/PS1 mice
Zhenri Ou et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease
Andre F. Batista et al.
JOURNAL OF PATHOLOGY (2018)
Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications
Geert Jan Biessels et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
Steven E. Arnold et al.
NATURE REVIEWS NEUROLOGY (2018)
Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease
Suzanne M. de la Monte et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial
Suzanne Craft et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives
Grazia Daniela Femminella et al.
JOURNAL OF DIABETES RESEARCH (2017)
Glucose Peaks and the Risk of Dementia and 20-Year Cognitive Decline
Andreea M. Rawlings et al.
DIABETES CARE (2017)
Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study
Aaron M. Koenig et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2017)
Targeting Insulin Signaling for the Treatment of Alzheimer's Disease
Yanxing Chen et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
Neuroinflammation impairs adaptive structural plasticity of dendritic spines in a preclinical model of Alzheimer's disease
Chengyu Zou et al.
ACTA NEUROPATHOLOGICA (2016)
Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes A Systematic Review and Meta-analysis
Nisa M. Maruthur et al.
ANNALS OF INTERNAL MEDICINE (2016)
APOE2 Eases Cognitive Decline during Aging: Clinical and Preclinical Evaluations
Mitsuru Shinohara et al.
ANNALS OF NEUROLOGY (2016)
PPARγ agonist pioglitazone improves cerebellar dysfunction at pre-Aβ deposition stage in APPswe/PS1dE9 Alzheimer's disease model mice
Junya Toba et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model
Liqin Qi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial
Jose A. Luchsinger et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
In Alzheimer's Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial
Michael Gejl et al.
FRONTIERS IN AGING NEUROSCIENCE (2016)
Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer's Disease and Other Neurodegenerative Diseases
Valeria Calsolaro et al.
CNS DRUGS (2015)
DPP-4 Inhibitor Linagliptin Attenuates Aβ-induced Cytotoxicity through Activation of AMPK in Neuronal Cells
Edy Kornelius et al.
CNS NEUROSCIENCE & THERAPEUTICS (2015)
Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration
Jeffrey J. Lochhead et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)
Early intervention with glucagon-like peptide 1 analog liraglutide prevents tau hyperphosphorylation in diabetic db/db mice
De-Lin Ma et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Restoration of Cerebral and Systemic Microvascular Architecture in APP/PS1 Transgenic Mice Following Treatment with Liraglutide™
Patricia Kelly et al.
MICROCIRCULATION (2015)
Anti-Diabetes Drug Pioglitazone Ameliorates Synaptic Defects in AD Transgenic Mice by Inhibiting Cyclin-Dependent Kinase5 Activity
Jinan Chen et al.
PLOS ONE (2015)
Long-Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer's Disease Dementia
Amy Claxton et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Evaluation of neuroprotective effect of glucagon-like peptide 1 analogs using neuroimaging
Grazia D. Femminella et al.
ALZHEIMERS & DEMENTIA (2014)
The incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer's disease
Christian Hoelscher
ALZHEIMERS & DEMENTIA (2014)
Insulin, incretins and other growth factors as potential novel treatments for Alzheimer's and Parkinson's diseases
Christian Hoelscher
BIOCHEMICAL SOCIETY TRANSACTIONS (2014)
Insulin Action in Brain Regulates Systemic Metabolism and Brain Function
Andre Kleinridders et al.
DIABETES (2014)
Long-Term Metformin Usage and Cognitive Function among Older Adults with Diabetes
Tze Pin Ng et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease
Paula L. McClean et al.
NEUROPHARMACOLOGY (2014)
Sulphonylurea Usage in Melioidosis Is Associated with Severe Disease and Suppressed Immune Response
Xiang Liu et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Insulin in the brain: its pathophysiological implications for states related with central insulin resistance, type 2 diabetes and alzheimer's disease
Enrique Blazquez et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
Glucagon-like peptide-1 (GLP-1) mimetics: a new treatment for Alzheimer's disease?
Natalia Garcia-Casares et al.
REVISTA DE NEUROLOGIA (2014)
Exendin-4 induced glucagon-like peptide-1 receptor activation reverses behavioral impairments of mild traumatic brain injury in mice
Lital Rachmany et al.
AGE (2013)
Intranasal Insulin as a Treatment for Alzheimer's Disease: A Review of Basic Research and Clinical Evidence
Jessica Freiherr et al.
CNS DRUGS (2013)
Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin
Eileen M. Moore et al.
DIABETES CARE (2013)
Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapy
S. Wheeler et al.
DIABETOLOGIA (2013)
Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art
Suzanne M. de la Monte
EXPERT OPINION ON DRUG DELIVERY (2013)
Subcutaneous Administration of Liraglutide Ameliorates Alzheimer-Associated Tau Hyperphosphorylation in Rats with Type 2 Diabetes
Yan Yang et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Sex and ApoE Genotype Differences in Treatment Response to Two Doses of Intranasal Insulin in Adults with Mild Cognitive Impairment or Alzheimer's Disease
Amy Claxton et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer's disease
Jayasankar Kosaraju et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
Liraglutide protects against amyloid-β protein-induced impairment of spatial learning and memory in rats
Wei-Na Han et al.
NEUROBIOLOGY OF AGING (2013)
The Diabetes Drug Liraglutide Ameliorates Aberrant Insulin Receptor Localisation and Signalling in Parallel with Decreasing Both Amyloid-β Plaque and Glial Pathology in a Mouse Model of Alzheimer's Disease
Caitriona M. Long-Smith et al.
NEUROMOLECULAR MEDICINE (2013)
Saxagliptin: A dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease
Jayasankar Kosaraju et al.
NEUROPHARMACOLOGY (2013)
THE INCRETIN ANALOGUE D-ALA2GIP REDUCES PLAQUE LOAD, ASTROGLIOSIS AND OXIDATIVE STRESS IN AN APP/PS1 MOUSE MODEL OF ALZHEIMER'S DISEASE
A. M. Duffy et al.
NEUROSCIENCE (2013)
Chronic Treatment with the GLP1 Analogue Liraglutide Increases Cell Proliferation and Differentiation into Neurons in an AD Mouse Model
Vadivel Parthsarathy et al.
PLOS ONE (2013)
Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study
Lieza G. Exalto et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial
Suzanne Craft et al.
ARCHIVES OF NEUROLOGY (2012)
Metformin Activates an Atypical PKC-CBP Pathway to Promote Neurogenesis and Enhance Spatial Memory Formation
Jing Wang et al.
CELL STEM CELL (2012)
Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
Konrad Talbot et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Metformin, Other Antidiabetic Drugs, and Risk of Alzheimer's Disease: A Population-Based Case-Control Study
Patrick Imfeld et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2012)
The many faces of insulin-like peptide signalling in the brain
Ana M. Fernandez et al.
NATURE REVIEWS NEUROSCIENCE (2012)
Risk of Alzheimer's Disease in Relation to Diabetes: A Population-Based Cohort Study
Kai-Chen Wang et al.
NEUROEPIDEMIOLOGY (2012)
A Randomized Pilot Clinical Trial of the Safety of Pioglitazone in Treatment of Patients With Alzheimer Disease
David S. Geldmacher et al.
ARCHIVES OF NEUROLOGY (2011)
Incidence of Dementia is Increased in Type 2 Diabetes and Reduced by the Use of Sulfonylureas and Metformin
Chih-Cheng Hsu et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
Paula L. McClean et al.
JOURNAL OF NEUROSCIENCE (2011)
Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease
Tomohiko Sato et al.
NEUROBIOLOGY OF AGING (2011)
Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer's Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study
Michael Gold et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2010)
Rosiglitazone and Cognitive Stability in Older Individuals With Type 2 Diabetes and Mild Cognitive Impairment
Angela M. Abbatecola et al.
DIABETES CARE (2010)
Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling
Eva Kickstein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Behind the rosiglitazone controversy
Bernard M. Y. Cheung
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2010)
Role of the incretin pathway in the pathogenesis of type 2 diabetes mellitus
J. S. FREEMAN
CLEVELAND CLINIC JOURNAL OF MEDICINE (2009)
Distinct modulation of voltage-gated and ligand-gated Ca2+ currents by PPAR-γ agonists in cultured hippocampal neurons
Tristano Pancani et al.
JOURNAL OF NEUROCHEMISTRY (2009)
PIOGLITAZONE IMPROVED COGNITION IN A PILOT STUDY ON PATIENTS WITH ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT WITH DIABETES MELLITUS
Giuseppe Bellelli et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2009)
The role of peroxisome proliferator-activated receptor-gamma (PPAR gamma) in Alzheimer's disease
Qingguang Jiang et al.
CNS DRUGS (2008)
Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-β in memory-impaired older adults
Mark A. Reger et al.
JOURNAL OF ALZHEIMERS DISEASE (2008)
PPARs in Alzheimer's Disease
Markus P. Kummer et al.
PPAR RESEARCH (2008)
Therapeutic use of agonists of the nuclear receptor PPARγ in Alzheimer's disease
Gary Landreth
CURRENT ALZHEIMER RESEARCH (2007)
Relation of diabetes to mild cognitive impairment
Jose A. Luchsinger et al.
ARCHIVES OF NEUROLOGY (2007)
Mechanisms of action of glucagon-like peptide 1 in the pancreas
Maire E. Doyle et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease
M. E. Risner et al.
PHARMACOGENOMICS JOURNAL (2006)
Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype
MA Reger et al.
NEUROBIOLOGY OF AGING (2006)
Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone - A preliminary study
GS Watson et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2005)
Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1-42 levels in APPV717I transgenic mice
MT Heneka et al.
BRAIN (2005)
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes?
E Steen et al.
JOURNAL OF ALZHEIMERS DISEASE (2005)
Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function
Z Arvanitakis et al.
ARCHIVES OF NEUROLOGY (2004)
分享论文
